Ivonescimab/Chemo Improves Quality of Life in Frontline Squamous NSCLC

Updated results from the phase 3 HARMONi-6 trial (NCT05840016) demonstrated that patient-reported quality of life outcomes were improved with ivonescimab plus chemotherapy compared with tislelizumab-jsgr (Tevimbra) plus chemotherapy in the…